These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 7249791)

  • 1. Reports on ceftriaxone (Rocephin).
    Chemotherapy; 1981; 27 Suppl 1():1-103. PubMed ID: 7249791
    [No Abstract]   [Full Text] [Related]  

  • 2. Reports on cephtriaxone (Rocephin). Introduction and review.
    Fernex M; Havas L
    Chemotherapy; 1981; 27 Suppl 1():1-8. PubMed ID: 7018850
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibacterial chemotherapy for treatment of infections in outpatient surgery.
    Flesch R
    Eur Surg Res; 1989; 21 Suppl 1():52-4. PubMed ID: 2737216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Stability of the ceftriaxone spectrum].
    Goldstein FW
    Presse Med; 1997 Feb; 26(3):120-1. PubMed ID: 9082430
    [No Abstract]   [Full Text] [Related]  

  • 5. Ceftriaxone is twice as cost-effective as standard therapy in biliary tract infection.
    Zoepf T; Jakobs R; Riemann JF
    Hepatogastroenterology; 2004; 51(58):941-5. PubMed ID: 15239219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftriaxone sodium (Rocephin, Roche).
    Roach AC
    Crit Care Nurse; 1985; 5(6):6, 8. PubMed ID: 3853506
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical study of Rocephin, a 3d generation cephalosporin, in various septicaemias.
    Ghosen V; Chamali R; Bar-Moshe O; Stenier P
    Chemotherapy; 1981; 27 Suppl 1():100-3. PubMed ID: 7249792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Choice of cephalosporins.
    Med Lett Drugs Ther; 1983 Jun; 25(637):57-60. PubMed ID: 6855695
    [No Abstract]   [Full Text] [Related]  

  • 9. The cephalosporins: targeting respiratory infections.
    Kessenich CR; Klotch DW; Cichon MJ
    Adv Nurse Pract; 2002 Nov; 10(11):18, 23-5. PubMed ID: 12478942
    [No Abstract]   [Full Text] [Related]  

  • 10. [Excretion of cefonicid and ceftriaxone into the saliva].
    Kelentey B; Fekete I; Kozma J
    Fogorv Sz; 1995 May; 88(5):159-62. PubMed ID: 8522009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ceftriaxone (Rocefin) in the treatment of bronchopulmonary infections].
    Nonikov VE; Konstantinova TD; Makarova OV; Manziuk EN; Minaev VI; Ritchik LA
    Ter Arkh; 1997; 69(10):84-8. PubMed ID: 9471801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity, pharmacokinetics, clinical efficacy, safety and pharmacoeconomics of ceftriaxone compared with third and fourth generation cephalosporins: review.
    Bijie H; Kulpradist S; Manalaysay M; Soebandrio A
    J Chemother; 2005 Feb; 17(1):3-24. PubMed ID: 15828439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The new cephalosporins.
    Villar LA; Donta ST
    J Iowa Med Soc; 1982 Jun; 72(6):246-8. PubMed ID: 7108289
    [No Abstract]   [Full Text] [Related]  

  • 14. Seminar on antibiotics IV. The cephalosporins.
    Rhoades ER
    J Okla State Med Assoc; 1980 Oct; 73(10):360-2. PubMed ID: 7431140
    [No Abstract]   [Full Text] [Related]  

  • 15. [Multicentre, randomized, prospective and comparative study of ceftriaxone, cefotaxime and cefuroxime in treating mild to moderate respiratory tract infection].
    Gao B; Hu J; Deng W
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):528-31. PubMed ID: 11360502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of a rational and consensual protocol for the use of ceftriaxone in a general hospital].
    Gómez Vargas J; Gómez J; Ruiz Gómez J; Simarro E; San Miguel T; Canteras M; Valdés M
    Rev Esp Quimioter; 1998 Dec; 11(4):327-32. PubMed ID: 9990146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftriaxone in the treatment of spontaneous bacterial peritonitis: ascitic fluid polymorphonuclear count response and short-term prognosis.
    Mesquita MA; Balbino EP; Albuquerque RS; Carmona CA; Okubo BT; Lorena SL; Montes CG; Soares EC
    Hepatogastroenterology; 1997; 44(17):1276-80. PubMed ID: 9356840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN; Sader HS; Fritsche TR; Pottumarthy S
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monotherapy with long half-life cephalosporins: example of ceftriaxone.
    Osborne JC
    Iowa Med; 1985 Oct; 75(10):460-6. PubMed ID: 4055303
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic attitude toward the new cephalosporins].
    Bergeron MG
    Union Med Can; 1984 Dec; 113(12):1041-8. PubMed ID: 6516062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.